Ultrasound Probe Disinfection Market to Worth USD 819.1 Million by 2023

The ultrasound probe disinfection market is projected to reach USD 819.1 million by 2023 from an estimated USD 314.1 million in 2018, at a CAGR of 21.1 percent. The key factors driving the growth of this market include the increasing number of ultrasound imaging procedures, rising incidence of hospital-acquired infections due to the improper reprocessing of ultrasound probes, increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, and technological advancements in ultrasound probes. On the basis of product, the ultrasound probe disinfection market is broadly segmented into consumables, instruments, and services. In 2018, the consumables segment is expected to account for the largest share of this market. This can majorly be attributed to the large number of commercially available disinfectants (as compared to other ultrasound probe disinfection products) in the market.

Based on process, the ultrasound probe disinfection market is segmented into high-level disinfection and intermediate/low-level disinfection. The high-level disinfection segment is estimated to register the highest CAGR. The growth of this segment is driven by the implementation of favorable government regulations and guidelines for effective probe disinfection, coupled with the growing incidence of HAIs. On the basis of the type of probe, the ultrasound probe disinfection market is broadly segmented into linear transducers, convex transducers, phased array transducers, endocavitary transducers, transesophageal echocardiography (TEE) transducers, and other probes (pencil transducers, concave transducers, and sector transducers). In 2018, the linear transducers segment is expected to account for the largest share of this market. Linear transducers are used for various applications, such as vascular examination, venipuncture, blood vessel visualization, intraoperative procedures, and laparoscopy. They come in contact with clean, intact skin, and are considered non-critical devices that require disinfection after every use and act as both a source and a vector for nosocomial infections.

Based on end user, the ultrasound probe disinfection market is segmented into hospitals & diagnostic imaging centers, maternity centers, ambulatory care centers, academic & research institutes, and other end users (physiotherapists, independent associations, government organizations, and sports academies). The ambulatory care centers segment is estimated to register the highest CAGR. The high growth in this end-user segment can be attributed to the increasing number of image-guided surgeries performed at ambulatory care centers, rising market demand for portable and compact ultrasound devices, and the procedural benefits offered by ultrasound in PoC applications. North America accounted for the largest share of the ultrasound probe disinfection market in 2018, followed by Europe. The increasing number of transvaginal, transrectal, abdominal, and intraoperative ultrasound procedures; growing number of TEE and ultrasound-guided interventional procedures (biopsies and venous access); rising adoption of high-level disinfectants; and the presence of leading market players in the region are the major factors responsible for the large share of North America in the ultrasound probe disinfection market.

The key players operating in the global ultrasound probe disinfection market are Nanosonics (Australia), CIVCO Medical Solutions (US), Tristel (UK), Ecolab (US), Germitec (France), Parker Laboratories (US), Schülke & Mayr (Germany), CS Medical (US), Virox Technologies (Canada), STERIS (UK), Advanced Sterilization Products (US), and Metrex Research (US). – MarketsandMarkets